Muscle wasting: The gut microbiota as a new therapeutic target?

被引:137
|
作者
Bindels, Laure B. [1 ]
Delzenne, Nathalie M. [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium
关键词
Muscle wasting; Gut microbiota; Undernutrition; Cachexia; Probiotics; Prebiotics; SKELETAL-MUSCLE; KAPPA-B; OBESITY; MODULATION; ACTIVATION; MALNUTRITION; RESISTANCE; AUTOPHAGY; PROTECTS; CACHEXIA;
D O I
10.1016/j.biocel.2013.06.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Muscle wasting is characterized by a loss of muscle mass and strength, and occurs in several pathological conditions such as cancer, chronic heart failure, chronic infection and malnutrition. Muscle wasting can be caused by inflammation and inappropriate nutritional status. Interestingly, gut microbiota has recently been proposed as an environmental factor involved, among others, in energy sparing from the diet, and in the regulation of host immunity and metabolism. This review presents evidence supporting the existence of a gut microbiota-muscle axis and discusses the potential role and therapeutic interest of gut microbiota in muscle wasting, specifically in the context of cancer and malnutrition. This review also proposes possible molecular mechanisms underlying the gut microbiota-muscle axis. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2186 / 2190
页数:5
相关论文
共 50 条
  • [21] Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?
    Zhang, Jiyao
    Tang, Qiang
    Zhu, Luwen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [22] The Gut Microbiota - A Realistic Therapeutic Target in Obesity and Metabolic Dysregulation
    Murphy, Eileen E.
    Cotter, Paul D.
    Hogan, Aileen
    O'Sullivan, Orla
    Joyce, Andy
    Fouhy, Fiona
    Clarke, Siobhan E.
    Marques, Tatiana M.
    O'Toole, Paul W.
    Stanton, Catherine
    Quigley, Eamonn M.
    Ross, Paul
    O'Doherty, Robert
    Shanahan, Fergus
    GASTROENTEROLOGY, 2011, 140 (05) : S103 - S104
  • [23] The gut microbiota: A novel therapeutic target in Parkinson's disease?
    Lubomski, Michal
    Davis, Ryan L.
    Sue, Carolyn M.
    PARKINSONISM & RELATED DISORDERS, 2019, 66 : 265 - 266
  • [24] Role and effective therapeutic target of gut microbiota in NAFLD/NASH
    Liu, Qun
    Liu, Shousheng
    Chen, Lizhen
    Zhao, Zhenzhen
    Du, Shuixian
    Dong, Quanjiang
    Xin, Yongning
    Xuan, Shiying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) : 1935 - 1944
  • [25] The gut microbiota: A new target in the management of alcohol dependence?
    Leclercq, Sophie
    Starkel, Peter
    Delzenne, Nathalie M.
    de Timary, Philippe
    ALCOHOL, 2019, 74 : 105 - 111
  • [26] Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
    Awoyemi, Ayodeji
    Hov, Johannes R.
    Troseid, Marius
    CIRCULATION-HEART FAILURE, 2023, 16 (01)
  • [27] Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence
    Zam, Wissam
    JOURNAL OF NUTRITION AND METABOLISM, 2018, 2018
  • [28] Gut microbiota as a promising therapeutic target for age-related sarcopenia
    Zhang, Ting
    Cheng, Jin-ke
    Hu, Yao-min
    AGEING RESEARCH REVIEWS, 2022, 81
  • [29] GUT MICROBIOTA AS A THERAPEUTIC TARGET TO AMELIORATE NEURAL INJURY IN AUTOIMMUNE NEUROPATHY
    Zhang, Gang
    Lin, Jianxin
    Gao, Tong
    Ganesh, Bhanu
    Sheikh, Kazim
    McCullough, Louise
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S148 - S149
  • [30] Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
    Suk, Ki Tae
    Kim, Dong Joon
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (03) : 193 - 204